---
tags:
  - iints/source
  - iints/source/guideline
source_id: "ada_2026_diabetes_technology"
source_bucket: "packaged_evidence"
category: "guideline"
component: "cgm_and_aid_context"
url: "https://doi.org/10.2337/dc26-S007"
doi: "10.2337/dc26-S007"
status: active
---

# Diabetes Technology: Standards of Care in Diabetes—2026

> [!info] What this source supports
> Reference for CGM and AID operational context used in report language and safeguards.

| Field | Value |
| --- | --- |
| Source ID | `ada_2026_diabetes_technology` |
| Bucket | `packaged_evidence` |
| Category | `guideline` |
| SDK component | `cgm_and_aid_context` |
| DOI | 10.2337/dc26-S007 |
| URL | https://doi.org/10.2337/dc26-S007 |
| Origin file | `src/iints/presets/evidence_sources.yaml` |

## Citation

American Diabetes Association Professional Practice Committee. Diabetes Care. 2026;49(Suppl 1).

## User Interpretation

Use this source to explain **why the SDK default, metric, dataset, or hardware-safety boundary exists**. It is evidence support for pre-clinical simulation and documentation, not a medical approval claim.
